11 Facts About Rino Rappuoli

Rino Rappuoli was born on 4 August 1952 and is an Italian immunologist.

Rino Rappuoli is the head of vaccine research and development at GlaxoSmithKline Vaccines.

Rino Rappuoli is known globally for his work in vaccines and immunology.

Rino Rappuoli co-founded the field of cellular microbiology, a discipline combining cell biology and microbiology, and pioneered the genomic approach to vaccine development known as reverse vaccinology, a subsection of reverse pharmacology.

Rino Rappuoli led Chiron Corporation's development of adjuvanted influenza vaccines, MENJUGATE conjugate vaccine against meningococcal-C disease and the first recombinant bacterial vaccine against pertussis.

Rino Rappuoli is actively involved in the research and development of further vaccines against meningococcal disease and avian and pandemic influenza.

Rino Rappuoli joined Chiron as head of European vaccines research in 1992 with the acquisition of Italian vaccines company Sclavo SpA, where he served as head of research and development.

Rino Rappuoli is the recipient of several prestigious awards, including the Paul Ehrlich and Ludwig Darmstaedter Prize in 1991.

Rino Rappuoli is a member of numerous international associations, including the European Molecular Biology Organization and the American Society for Microbiology.

Rino Rappuoli serves as a member of the research directors group of the European Commission and in 2005 was elected to National Academy of Sciences of the United States.

Rino Rappuoli was awarded the Italian President Gold Medal in 2005 and the Albert Sabin Gold Medal in 2009.